MODULE - HIV-105
TITLE - The Specialty Pharmacist's Role in the Management of the Treatment of HIV Patients
TARGET AUDIENCE - Target audiences for this program are Specialty Pharmacists, Pharmacists, Clinical Pharmacists, Specialty Pharmacy executives, Pharmacy Directors, Chief Pharmacy Officers, Nurses, and Infusion Nurses.
LEARNING OBJECTIVES - After completing the program, Specialty Pharmacists, Pharmacists, Clinical Pharmacists, Specialty Pharmacy executives, Pharmacy Directors, Chief Pharmacy Officers, Nurses, and Infusion Nurses along with other healthcare practitioner participants will be able to:
- Define treatment failure and describe when to recommend a change in therapy
- Describe the testing necessary to determine which antiretroviral agents to switch to when resistance is determined
- Review factors influencing choices for the classification of therapies as second and third line
- Management of side effects of second line agents
- Discuss future antiretroviral in the investigational pipeline and how to link or enroll patients in clinical trials
- Identify the three biggest barriers to adherence and compliance for the HIV patient concerning treatment-resistant HIV infection
- Recognize the three most important clinical and three non-clinical considerations concerning the specialty pharmacist in HIV treatment resistant infection
Before the activity, all faculty and anyone who is in a position to have control over the content of this activity and their spouse/life partner will disclose the existence of any financial interest and/or relationship(s) they might have with any commercial interest producing healthcare goods/ services to be discussed during their presentation(s): honoraria, expenses, grants, consulting roles, speakers bureau membership, stock ownership, or other special relationships. Presenters will inform participants of any off-label discussions. All identified conflicts of interest are thoroughly vetted by the Specialty Pharma Education Center for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations.
Pharmacist continuing education credit
Educational Review Systems is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmaceutical education. This program is approved for 1 hours (0.1CEUs) of continuing pharmacy education credit. Proof of participation will be posted to your NABP CPE profile within 4 to 6 weeks to participants who have successfully completed the post-test. Participants must participate in the entire presentation and complete the course evaluation to receive continuing pharmacy education credit.
ACPE # 0761-9999-13-405-H02-P
Knowledge based activity
Nursing continuing education credit
Educational Review Systems is an approved provider of continuing education in nursing by ASNA, an accredited provider by the ANCC/Commission on Accreditation. Provider # 5-115. This program is approved for 1 hours of continuing nursing education.
Educational Review Systems is also approved for nursing continuing education by the state of California, the state of Florida and the District of Columbia.
Course release date 11/01/2013
Course expires 11/01/2016
|Activity Number||Credit Amount||Accreditation Period|
|0761-9999-13-405-H02-N||1 hour of CNE||from November 01, 2013|